ImmuPharma plc (LON:IMM – Get Free Report)’s stock price was up 79.2% during trading on Thursday . The stock traded as high as GBX 2.49 ($0.03) and last traded at GBX 2.15 ($0.03). Approximately 21,651,871 shares traded hands during mid-day trading, an increase of 379% from the average daily volume of 4,518,033 shares. The stock had previously closed at GBX 1.20 ($0.01).
ImmuPharma Stock Up 4.9 %
The stock has a 50 day simple moving average of GBX 1.40 and a 200 day simple moving average of GBX 1.65. The company has a market cap of £15.30 million, a price-to-earnings ratio of -367.30 and a beta of 1.53.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Further Reading
- Five stocks we like better than ImmuPharma
- Options Trading – Understanding Strike Price
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What is Insider Trading? What You Can Learn from Insider Trading
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What Are Earnings Reports?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
